BREVICON 0.5/35 TABLETS (28-DAY PACK)
PFIZER CANADA ULC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of BREVICON 0.5/35 TABLETS (28-DAY PACK) in Canada?
Yes. BREVICON 0.5/35 TABLETS (28-DAY PACK) .5MG .035MG has an active shortage reported to Health Canada (last updated May 19, 2026).
Why is BREVICON 0.5/35 TABLETS (28-DAY PACK) not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will BREVICON 0.5/35 TABLETS (28-DAY PACK) be available again?
The manufacturer's estimated resolution date is March 19, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02187094
Strength
.5MG .035MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
NORETHINDRONE ETHINYL ESTRADIOL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Other Products from PFIZER CANADA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 02511053
20MG · DIN 02511061
40MG · DIN 02511045
DIN 02544040
5MG · DIN 01947664
10MG · DIN 01947672
20MG · DIN 01947680
40MG · DIN 01947699
DIN 02237367
DIN 02237368
DIN 02237369
50MG · DIN 02401347